TR200100338T2 - Ödem tedavisinde kullanılan TNF-türevleri peptitler. - Google Patents

Ödem tedavisinde kullanılan TNF-türevleri peptitler.

Info

Publication number
TR200100338T2
TR200100338T2 TR2001/00338T TR200100338T TR200100338T2 TR 200100338 T2 TR200100338 T2 TR 200100338T2 TR 2001/00338 T TR2001/00338 T TR 2001/00338T TR 200100338 T TR200100338 T TR 200100338T TR 200100338 T2 TR200100338 T2 TR 200100338T2
Authority
TR
Turkey
Prior art keywords
tnf
edema
alpha
treatment
present
Prior art date
Application number
TR2001/00338T
Other languages
English (en)
Turkish (tr)
Inventor
Lucas Rudolf
Baetseller Patrick
Pugin Jerome
Bloc Alain
Fransen Lucie
Original Assignee
Innogenetics N.V.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Innogenetics N.V. filed Critical Innogenetics N.V.
Publication of TR200100338T2 publication Critical patent/TR200100338T2/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19—Cytokines; Lymphokines; Interferons
    • A61K38/191—Tumor necrosis factors [TNF], e.g. lymphotoxin [LT], i.e. TNF-beta
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/10—Antioedematous agents; Diuretics
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • C07K14/525—Tumour necrosis factor [TNF]

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Molecular Biology (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Toxicology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Pulmonology (AREA)
  • Obesity (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
TR2001/00338T 1998-08-14 1999-08-10 Ödem tedavisinde kullanılan TNF-türevleri peptitler. TR200100338T2 (tr)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP98870180 1998-08-14
EP98870198 1998-09-18
EP98870222 1998-10-21

Publications (1)

Publication Number Publication Date
TR200100338T2 true TR200100338T2 (tr) 2001-12-21

Family

ID=27239778

Family Applications (1)

Application Number Title Priority Date Filing Date
TR2001/00338T TR200100338T2 (tr) 1998-08-14 1999-08-10 Ödem tedavisinde kullanılan TNF-türevleri peptitler.

Country Status (20)

Country Link
US (2) US20030105021A1 (https=)
EP (3) EP1264599B1 (https=)
JP (1) JP4542266B2 (https=)
CN (1) CN1181886C (https=)
AT (2) ATE395072T1 (https=)
AU (1) AU764992B2 (https=)
BR (1) BR9912899A (https=)
CA (1) CA2334941C (https=)
CZ (1) CZ302862B6 (https=)
DE (2) DE69938743D1 (https=)
DK (1) DK1264599T3 (https=)
ES (1) ES2296872T3 (https=)
HU (1) HU227661B1 (https=)
IL (2) IL141064A0 (https=)
NZ (1) NZ509604A (https=)
PL (1) PL203706B1 (https=)
PT (1) PT1264599E (https=)
TR (1) TR200100338T2 (https=)
WO (1) WO2000009149A1 (https=)
ZA (1) ZA200100656B (https=)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU764992B2 (en) 1998-08-14 2003-09-04 LUCAS, Rudolf Dr. TNF-derived peptides for use in treating oedema
CA2575513C (en) 2004-08-06 2014-09-16 Altana Pharma Ag Composition comprising a pulmonary surfactant and a tnf-derived peptide
EP2009023A1 (en) * 2007-06-04 2008-12-31 Rentschler Beteiligungs GmbH Novel peptides and their use for the treatment of edema
AT506150B1 (de) * 2007-12-12 2010-01-15 Apeptico Forschung Und Entwick Zyklisches und cystein-freies peptid
AT506151B1 (de) * 2007-12-12 2010-01-15 Apeptico Forschung Und Entwick Fusionsprotein
AT507953B1 (de) * 2009-03-05 2011-02-15 Apeptico Forschung & Entwicklung Gmbh Verfahren zur vermeidung und zur behandlung einer hyperpermeabilität
AT509267A1 (de) * 2010-01-14 2011-07-15 Apeptico Forschung & Entwicklung Gmbh Organische verbindungen zur regulierung von vektoriellen ionenkanälen
DK2397151T3 (en) * 2010-06-21 2015-05-18 Apeptico Forschung & Entwicklung Gmbh The treatment of the vascular complications of diabetes
AT510585B1 (de) * 2010-11-18 2012-05-15 Apeptico Forschung & Entwicklung Gmbh Zusammensetzung umfassend ein peptid und ein hemmstoff der viralen neuraminidase
US11161881B2 (en) * 2010-11-18 2021-11-02 Apeptico Forschung Und Entwicklung Gmbh Composition comprising a peptide and an inhibitor of viral neuraminidase
EP2679239A1 (de) * 2012-06-28 2014-01-01 Apeptico Forschung und Entwicklung GmbH Pharmazeutische Zusammensetzung zur Behandlung der durch Sauerstoffarmut und verringerten Luftdruck vermittelten pulmonalen Form der Höhenkrankheit
US12004506B2 (en) 2013-04-23 2024-06-11 Apeptico Forschung Und Entwicklung Gmbh Pharmaceutical composition comprising a cyclic peptide of formula X1-GQRETPEGAEAKPWY-X2 and use for extracorporeal lung treatment
KR102113501B1 (ko) * 2013-04-23 2020-05-22 아펩티코 포어슝 운트 엔트빅크룽 게엠베하 식 ｘ₁－ｇｑｒｅｔｐｅｇａｅａｋｐｗｙ－ｘ₂의 고리 펩티드를 포함하는 제약 조성물 및 체외 폐 치료를 위한 사용
WO2015140125A2 (en) 2014-03-18 2015-09-24 Apeptico Forschung Und Entwicklung Gmbh Dry-powder peptide medicament
CN110613838A (zh) * 2018-06-19 2019-12-27 姜石松 增强细胞通透性的多肽及其应用
CN119264211A (zh) 2018-08-27 2025-01-07 瑞泽恩制药公司 拉曼光谱在下游纯化中的应用
EP4051307B1 (en) 2020-05-08 2023-02-01 APEPTICO Forschung und Entwicklung GmbH Peptide for prevention or treatment of covid-19

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE384179C (de) * 1921-04-07 1923-10-27 Ludwig Weil Dr Laufrad fuer Kreiselpumpen und -geblaese
DE3841759A1 (de) 1988-12-12 1990-06-13 Basf Ag Neue tnf-peptide
US5891679A (en) 1993-02-03 1999-04-06 N.V. Innogenetics S.A. TNF-alpha muteins and a process for preparing them
AU764992B2 (en) 1998-08-14 2003-09-04 LUCAS, Rudolf Dr. TNF-derived peptides for use in treating oedema

Also Published As

Publication number Publication date
EP1247531A2 (en) 2002-10-09
EP1105152A1 (en) 2001-06-13
IL141064A0 (en) 2002-02-10
ZA200100656B (en) 2005-06-29
US20030105021A1 (en) 2003-06-05
HU227661B1 (hu) 2011-10-28
EP1264599A1 (en) 2002-12-11
JP2002522508A (ja) 2002-07-23
DE69937206D1 (de) 2007-11-08
US20030185791A1 (en) 2003-10-02
ATE374039T1 (de) 2007-10-15
CN1181886C (zh) 2004-12-29
AU5620999A (en) 2000-03-06
HUP0103117A3 (en) 2004-03-01
CN1312724A (zh) 2001-09-12
AU764992B2 (en) 2003-09-04
EP1264599B1 (en) 2007-09-26
DE69937206T2 (de) 2008-06-19
EP1247531B1 (en) 2008-05-14
EP1247531A3 (en) 2002-12-18
PT1264599E (pt) 2008-01-07
PL345997A1 (en) 2002-01-14
HUP0103117A2 (hu) 2001-12-28
NZ509604A (en) 2003-05-30
ES2296872T3 (es) 2008-05-01
CZ2001538A3 (cs) 2001-08-15
BR9912899A (pt) 2001-05-08
WO2000009149A1 (en) 2000-02-24
HK1051805A1 (en) 2003-08-22
ATE395072T1 (de) 2008-05-15
DE69938743D1 (de) 2008-06-26
IL141064A (en) 2009-09-01
CZ302862B6 (cs) 2011-12-21
DK1264599T3 (da) 2008-02-04
PL203706B1 (pl) 2009-11-30
JP4542266B2 (ja) 2010-09-08
CA2334941C (en) 2011-08-09
US7258861B2 (en) 2007-08-21
CA2334941A1 (en) 2000-02-24

Similar Documents

Publication Publication Date Title
TR200100338T2 (tr) Ödem tedavisinde kullanılan TNF-türevleri peptitler.
DK1337157T3 (da) Proteinhydrolysater
ES2160485A1 (es) Peptidos inhibidores de la exorcitosis neuronal, composiciones cosmeticas y farmaceuticas que los contienen.
IL161591A (en) Peptides effective in the treatment of tumors and other conditions requiring the removal or destruction of cells
WO2002015922A3 (en) New uses for amino acid anticonvulsants for treatment of pain
EA200000933A1 (ru) Пептидные композиции и препараты и их применение
GEP20043407B (en) Method of Inhibiting Amyloid Protein Aggregation and Imaging Amyloid Deposits Using Isoindoline Derivatives
DE60331546D1 (de) Verwendung von aspartic proteasen in den bereichen kosmetik und behandlung
DE60217326D1 (de) Von neurofilamentproteinen abgeleitete peptide und deren medizinische verwendung
DE60213648D1 (de) Verwendung von thymulinähnlichen peptiden zur herstellung von schmerzmitteln
BR0012418A (pt) Derivados de peptìdeo cìclicos como inibidores de integrina alfavbeta6
ATE443076T1 (de) Von protease typ ii spaltbares peptid
DE60231825D1 (de) Behandlung von infektionen verursacht von mikroorganismen
TW326395B (en) Water-based hair treatment composition as heat-safe preparation and method of using same
DE69329899D1 (de) Behandlung von tropikalischer spastischer Paresis mit Peptide T
DE69330268D1 (de) Hämoregulierende peptide
DE60104695D1 (de) Zusammensetzungen aus aminosäuren zur behandlung von herzinsuffizienz
EP1557466A4 (en) TUMORANT PROPERTIES AND USE THEREOF
FI20012082A0 (fi) Biologisesti aktiiviset peptidit hermovauroiden korjaamiseksi
ATE346862T1 (de) Aus pflanzen gewonnene peptide mit wasserreinigender und antimikrobieller wirkung
DE60143025D1 (de) Zusammensetzung zur behandlung von periodontalen erkrankungen